Key Dates

Related Announcements

• October 2 2024 - Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Lung Cancer Screening (UG3/UH3 Clinical Trial Required). See  RFA-CA-25-009.
• October 2, 2024 - Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) -Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required). See  RFA-CA-25-010.

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute's Division of Cancer Control and Population Sciences (DCCPS) will hold a pre-application webinar for RFA-CA-25-009, “Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Lung Cancer Screening (UG3/UH3 Clinical Trial Required)” and RFA-CA-25-010, “Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)”.

The pre-application webinar, to be held on Monday, October 28, 2024, from 12:00 pm – 1:00 pm ET, will include an overview of the notices of funding opportunity (NOFO) as well as specific requirements for applications submitted in response to each of the NOFOs. The webinar will conclude with an open question and answer session. Potential applicants are encouraged to submit their questions in advance to [email protected].

Note: Questions about the scope of the two NOFOs will be addressed during the webinar; however, questions about investigators' specific study aims will not be addressed in the webinar and can be directed to one of the points of contact for these NOFOs.

Registration for the webinar is required. Register at: https://cbiit.webex.com/weblink/register/r56df48f2a2ac38b2017d0b9687749d2a.

Following this webinar, NCI DCCPS will link to a recording on https://cancercontrol.cancer.gov/is/about/events.

Inquiries

Please direct all inquiries to [email protected].